For years, Medicare drug coverage carried a trap that caught patients by surprise every summer. After a plan and a beneficiary had spent a certain amount, coverage shrank and the person suddenly paid far more at the pharmacy counter, a phase widely known as the Part D “donut hole.” That gap is now gone. A redesign of the program has replaced it with a firm annual limit on what any enrollee pays out of pocket for covered prescriptions, which means drug costs no longer jump partway through the year the way they once did.
How the coverage gap used to work
Under the old structure, Part D coverage moved through stages tied to spending. A beneficiary paid a share of drug costs until combined spending reached a threshold, at which point the plan’s help fell away and the person entered the gap. Inside that window, out-of-pocket costs climbed sharply, and someone taking several expensive medications could hit it by midsummer. Medicare’s own guidance on what enrollees pay for drug coverage once devoted whole sections to explaining the phase.
The practical result was a budgeting nightmare. A retiree could pay a manageable copay in the spring, then watch the same prescription cost several times as much once the gap kicked in, only for costs to drop again after enough spending pushed them into catastrophic coverage. Predicting the yearly total was difficult, and the mid-year spike hit hardest for people on fixed incomes managing chronic conditions.
Lawmakers narrowed the gap gradually over more than a decade, requiring drugmakers and plans to cover more of the cost inside the window. Even so, the underlying design still produced a stretch of the year when many enrollees paid a larger share, and the phase remained a defining feature of Part D that patients had to plan around.
Free retirement updates: Social Security and Medicare change every year, and nobody sends a memo. The free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
What replaced the gap in the redesigned program
The current design does away with the gap phase entirely and sets a single hard ceiling on annual out-of-pocket spending for covered drugs. In 2025 that cap sat at $2,000, and it is indexed to rise in later years, reaching a confirmed $2,400 for 2027 under the schedule Medicare has finalized. Once a beneficiary reaches the limit, they pay nothing more for covered prescriptions for the rest of the calendar year, as Medicare explains in its overview of what Part D plans cover.
That change turns an unpredictable cost into a known maximum. A person who takes high-priced specialty medication no longer faces the old cliff where coverage thinned midway through the year. Instead, spending accumulates steadily toward the cap, and after that point the pharmacy bill stops entirely for covered drugs.
The redesign also added a way to spread payments across the year. Enrollees can now choose to pay their out-of-pocket drug costs in level monthly installments rather than large sums at the counter, smoothing the burden for anyone who would otherwise face heavy bills early in the year. Medicare’s summary of program costs outlines how the pieces fit together.
How the new ceiling changes drug spending
The most immediate effect is certainty. A retiree can now look at the annual cap and know that no matter how expensive their prescriptions are, covered-drug spending will not exceed that figure in a year. For households that once dreaded the summer months when the gap arrived, the change removes a recurring source of financial stress.
The cap also reshapes decisions about when to fill prescriptions. Under the old system, some patients delayed or rationed medication to avoid triggering the gap, a choice that could harm their health. With a flat annual limit and the option to spread payments, the incentive to skip doses to dodge a mid-year spike largely disappears.
The ceiling is not fixed at its first-year level, because it climbs with inflation each year. For 2026 the cap rose to $2,100, up from the $2,000 that applied in 2025, and it is set to reach $2,400 in 2027 under the schedule Medicare has finalized. Once a beneficiary hits that annual figure, catastrophic coverage takes over automatically and the plan pays the full cost of covered drugs for the balance of the year. The practical meaning is that the most a household can spend on covered prescriptions is knowable in advance and rises only in small, published steps rather than through the sudden mid-year jumps the old gap produced. For a retiree budgeting a year ahead, that predictability is the substance of the change, because the yearly ceiling can be written into a plan the way a fixed premium or a rent figure can.
The ceiling applies only to covered drugs under a Part D or Medicare Advantage drug plan, so a medication a plan does not cover still falls outside the protection, and premiums and deductibles remain separate. Even with those boundaries, the shift from an unpredictable gap to a fixed annual maximum is one of the largest changes to what older Americans pay for medicine in the program’s history, and it means the calendar no longer dictates when a prescription suddenly becomes unaffordable.
This article was produced with AI assistance and reviewed by The Money Overview editorial team.
More Financial Reading
